Search - tctmd.com

Displaying 361 - 380 of 2029

Sort: Relevancy | Date

Presentation

Evaluation of a Crystalline SES With a Bioabsorbable Polymer Designed for Rapid Dissolution

Presenter: William Wijns

October 01, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

News Industry News

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

September 29, 2015

News Daily News

研究表明对多支血管CAD采取多支动脉CABG有益

Todd Neale

September 24, 2015

News Daily News

Un Estudio Avala la CABG Multiarterial para el Manejo de la EAC Multivaso

Todd Neale

September 24, 2015

News Daily News

Study Supports Multiarterial CABG for Multivessel CAD

Todd Neale

September 24, 2015

Presentation

Single-Arterial or Multiarterial CABG vs PCI With DES or BMS for Multivessel CAD

Presenter: RH. Habib

September 23, 2015

News Industry News

Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES™ Coronary Stent System

September 23, 2015

News Industry News

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

September 21, 2015

Presentation Aortovascular 2015

The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet?

Presenter: Danielle R. Bajakian

September 18, 2015

Presentation Aortovascular 2015

Scaffolds, Injectables, Tacks, Smashers, etc: Future endovascular therapies

Presenter: William A. Gray

September 18, 2015

News Daily News

OPTIMAX: Prometedores Primeros Resultados en Humanos de un Stent Biocompatible de Cobalto-Cromo

Yael L. Maxwell

September 14, 2015

News Daily News

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

Yael L. Maxwell

September 14, 2015

News Daily News

OPTIMAX：生物相容性钴铬支架的首例人类结果前景看好

Yael L. Maxwell

September 14, 2015

News Industry News

First Patient Enrolled in CeloNova’s e-COBRA Clinical Registry

September 14, 2015

News Industry News

QT Vascular wins CE Mark for drug-coated balloon

September 10, 2015

Presentation

Clinical Outcome of Titanium-Nitride-Oxide-Coated Cobalt-Chromium Stents

Presenter: Pasi P. Karjalainen

September 10, 2015

News Conference News ESC 2015

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

Caitlin E. Cox

September 02, 2015

News Industry News

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

September 01, 2015

Presentation ESC 2015

12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions

Presenter: Takeshi Kimura

September 01, 2015

Advertisement

Evaluation of a Crystalline SES With a Bioabsorbable Polymer Designed for Rapid Dissolution

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

研究表明对多支血管CAD采取多支动脉CABG有益

Un Estudio Avala la CABG Multiarterial para el Manejo de la EAC Multivaso

Study Supports Multiarterial CABG for Multivessel CAD

Single-Arterial or Multiarterial CABG vs PCI With DES or BMS for Multivessel CAD

Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES™ Coronary Stent System

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet?

Scaffolds, Injectables, Tacks, Smashers, etc: Future endovascular therapies

OPTIMAX: Prometedores Primeros Resultados en Humanos de un Stent Biocompatible de Cobalto-Cromo

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

OPTIMAX：生物相容性钴铬支架的首例人类结果前景看好

First Patient Enrolled in CeloNova’s e-COBRA Clinical Registry

QT Vascular wins CE Mark for drug-coated balloon

Clinical Outcome of Titanium-Nitride-Oxide-Coated Cobalt-Chromium Stents

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content